InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-14.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Pellini Michael J, Director. Director active across 3 companies, notably Singular Genomics Systems, Inc.. In total, 12 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €85k. Activity tracked since 26 January 2022. The latest transaction was disclosed on 4 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
15,394 shares0Common StockSEC:0001062993-25-004807:0
26,834 sharesCommon StockSEC:0000950170-25-027099:0
31,328 shares0Common StockSEC:0001062993-24-005775:0
14,775 shares0Common StockSEC:0001062993-23-006337:0
4,278 sharesClass A Common StockSEC:0001209191-22-054001:0
60,668 shares@ US$0.210812.4% of flowCommon StockSEC:0001209191-22-034752:0
26,834 shares@ US$3.3087.6% of flowCommon StockSEC:0001209191-22-030584:0
Ideal exit: 12 Feb 2023 (T+270)
12,836 sharesClass A Common StockSEC:0001209191-22-028693:0
6,689 shares0Common StockSEC:0001209191-22-005499:0
6,689 shares0Common StockSEC:0001209191-22-005499
96,944 sharesCommon StockSEC:0001209191-21-037021
96,944 sharesCommon StockSEC:0001209191-21-037021:0
12 of 12 declarations
About Pellini Michael J
Pellini Michael J serves as a Board Member at Singular Genomics Systems, Inc., Adaptive Biotechnologies Corp, and Sema4 Holdings Corp. In this role, he oversees operations and participates in strategic decision-making. His expertise in the biopharmaceutical sector is essential in guiding the companies towards sustainable growth.
